Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Benefit of interferon beta-1a on MSFC progression in secondary progressive MS.
Implications of Real-world Adherence on Cost-effectiveness Analysis in Multiple Sclerosis.
Novartis announces Russian regulatory approval for Gilenya®, a once-daily oral multiple sclerosis therapy and first in a new class
Effects of fumarates on circulating and CNS myeloid cells in multiple sclerosis.
Origin, fate and dynamics of macrophages at central nervous system interfaces.
Annual incidence, prevalence, and mortality of multiple sclerosis in white South-African-born and in white immigrants to South Africa.
Development of Guillain-Barré syndrome in a patient with multiple sclerosis during treatment with glatiramer acetate.
Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial.
Thyroid autoimmunity and dysfunction in multiple sclerosis patients during long-term treatment with interferon beta or glatiramer acetate: an Italian multicenter study.
Alpha/beta interferon is a neuronal growth factor.
Vitamin D as an Early Predictor of Multiple Sclerosis Activity and Progression.
CCL genes in multiple sclerosis and systemic lupus erythematosus.
Acute disseminated encephalomyelitis in 228 patients: A retrospective, multicenter US study.
Effect of therapeutic horseback riding on balance and gait of people with multiple sclerosis.
Glatiramer acetate increases phagocytic activity of human monocytes in vitro and in multiple sclerosis patients.
JC polyomavirus mutants escape antibody-mediated neutralization.
Anti-inflammatory dimethylfumarate: a potential new therapy for asthma?
Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group.
Extraocular Source of Oligodendrocytes Contribute to Retinal Myelination and Optokinetic Responses in Zebrafish.
The use of cytokine signature patterns: separating drug naïve, interferon and natalizumab-treated multiple sclerosis patients.
Betaseron (Interferon Beta-1b) for SC Injection
Mitoxantrone induces natural killer cell maturation in patients with secondary progressive multiple sclerosis.
Neuromyelitis optica spectrum disorder (NMOSD): A new concept.
Full Prescribing Information, Copaxone (glatiramer acetate)
Effects of Interferon β-1a and Interferon β-1b Monotherapies on Selected Serum Cytokines and Nitrite Levels in Patients with Relapsing-Remitting Multiple Sclerosis: A 3-Year Longitudinal Study.

Pages